Research & development at Boehringer Ingelheim is conducted at three major research & development sites and two support centres worldwide. We employ more than 7,000 scientists, technicians and support staff, clinical monitors, statisticians and data managers. Clinical research is conducted in 87 countries all over the world.
The bridge between industry and academia is strengthened by the Research Institute of Molecular Pathology (IMP) in Vienna (Austria)
Support centre for non-clinical drug development:
Support centre for chemical synthesis: